Procurement of tofacitinib medicines for 2027

Summary

Amgros I/S is procuring tofacitinib medicines for hospital pharmacies and other designated delivery locations in Denmark under three independently awarded framework-agreement lots. The lots cover 5 mg and 10 mg tablets (estimated quantities of 156,576 and 63,728 units), 1 mg/ml oral solution (336 units), and 11 mg prolonged-release tablets (14,106 units). The ordinary purchasing period is 1 April 2027 to 31 March 2028, with an option to extend each agreement once by up to six months.